These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2161575)

  • 21. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids.
    Jackisch R; Hotz H; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):234-41. PubMed ID: 8232601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13).
    Lemaire S; Dumont M; Jolicoeur F; Belleau B
    Can J Physiol Pharmacol; 1986 Jun; 64(6):707-11. PubMed ID: 2875779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative contribution of endogenous opioids to myocardial ischemic tolerance.
    Romano MA; Seymour EM; Berry JA; McNish RA; Bolling SF
    J Surg Res; 2004 May; 118(1):32-7. PubMed ID: 15093714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of dynorphin A and related peptides to kappa- and mu-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p.
    Gairin JE; Botanch C; Cros J; Meunier JC
    Eur J Pharmacol; 1989 Oct; 172(4-5):381-4. PubMed ID: 2573538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
    Weyhenmeyer JA; Mack KJ
    Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kappa-type opioid receptor in human placental membrane].
    Ohta S; Niwa M; Nozaki M; Tsurumi K; Shimonaka H; Tanahashi T; Uematsu H; Yamamoto M; Fujimura H
    Masui; 1989 Oct; 38(10):1293-300. PubMed ID: 2555580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two classes of opioid binding sites in Drosophila melanogaster head membranes.
    Santoro C; Hall LM; Zukin RS
    J Neurochem; 1990 Jan; 54(1):164-70. PubMed ID: 2152792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sodium ion on the affinity of naloxone for the kappa opioid receptor.
    Cheney BV; Lahti RA
    Life Sci; 1987 Mar; 40(11):1071-4. PubMed ID: 3029528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species differences in the concentrations and distributions of opioid binding sites.
    Robson LE; Gillan MG; Kosterlitz HW
    Eur J Pharmacol; 1985 May; 112(1):65-71. PubMed ID: 2990966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Brenner AS; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):156-62. PubMed ID: 2871497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.